Please login to the form below

Not currently logged in
Email:
Password:

Glenmark

This page shows the latest Glenmark news and features for those working in and with pharma, biotech and healthcare.

EMA suspends generic drugs on data integrity concerns

EMA suspends generic drugs on data integrity concerns

Included in the lengthy list of medicines affected by the suspension are products sold by Sandoz, Teva, Mylan, Sanofi, Biogaran Ratiopharm, Glenmark and Accord Healthcare, amongst many other firms, and most

Latest news

  • Indian court blocks generic of Merck's Januvia Indian court blocks generic of Merck's Januvia

    India's Supreme Court has prevented Glenmark Pharmaceuticals from making and selling a generic of Merck &Co's diabetes blockbuster Januvia. ... Glenmark was ordered to pay part of Merck's legal fees but was excused compensation.

  • UCB files Vimpat patent claims against 15 companies UCB files Vimpat patent claims against 15 companies

    UCB files Vimpat patent claims against 15 companies. Aurobindo, Glenmark, Mylan, Ranbaxy and Sandoz all face legal challenge over generic versions of UCB's epilepsy drug. ... These other firms include major players in the generics market, such as Glenmark

  • Merck wins injunction against Januvia generics in India Merck wins injunction against Januvia generics in India

    The patent infringement case against Glenmark centred on the salt form of sitagliptin used in Zita and Zita Met. ... why the courts have blocked Aprica's products whilst letting Glenmark's remain on the market.

  • Merck & Co fails to block generic Januvia in India Merck & Co fails to block generic Januvia in India

    Merck &Co fails to block generic Januvia in India. Court says Glenmark can sell cheap copy of diabetes drug. ... of its price in the US – while Glenmark's versions are sold at a 20-30 per cent discount.

  • Bayer sues Glenmark over its skin disorder generic Bayer sues Glenmark over its skin disorder generic

    Bayer sues Glenmark over its skin disorder generic. India-based firm files for US approval of its version of Finacea. ... Bayer has launched a lawsuit against Glenmark Generics after the India-based firm filed for US approval of a generic version of skin

More from news
Approximately 4 fully matching, plus 21 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics